August 15 Covid deaths, hospitalizations and ICU stays

Last Friday, FDA’s advisory committee (VRBPAC) voted 16 to 2 against giving a license to a third Pfizer booster shot for everyone age 16 and up. Although a second vote at Friday’s meeting had not been planned, another question was hastily developed. That question asked whether the vaccine could be licensed for a third booster…
“We had to do something about swine flu!” And so the makers of Tamiflu (oseltamvir) are several billion dollars richer. As the BMJ (a.k.a. British Medical Journal) put it in 2005: “From a bit of a dud to the world’s most sought after drug in the space of six months, surely Roche cannot believe its…
As long as the research is methodologically sound and designed to capture a broad range of possible adverse outcomes from radiation released at Fukushima (where people have been exposed to many different isotopes through skin contact, inhalation and ingestion at widely varying doses), you will probably learn a lot about how the radiation affected health. …
Megan Redshaw has been doing an excellent job covering scientific issues for the Defender. This article explores the issue of vaccinating people who have recovered from Covid, and how it might cause high rates of adverse reactions. The AIER has also recently published an article on this subject, here. Update April 14: new Lancet commentary…
The World Press Freedom Index is issued yearly by international NGO Reporters Without Borders. The methodology for ranking nations is described here. 180 nations are included. At #46, the US is assessed as having less freedom of the press than Papua-New Guinea, Romania, Slovenia, Latvia, and South Africa, to pick a few. However, we did beat…
Reuters, Dec. 11: Boosters significantly restore protection vs Omicron, UK says Reuters, Dec. 22: ‘Significant increase’ in protection vs Omicron from mRNA boosters, study says NYT, Dec. 23 Booster protection wanes against symptomatic Omicron infections, British data suggests. The only thing you can come away with, from these headlines, is that at least one of…
Comments are closed.
*FLASH* *ALL SHIPS AT SEA*
"$2.8 million 'bribe payment from Pfizer to FDA?' for their Bioweapon “approval”. You’re not supposed to know that. Look the other way." Govt/FDA now saying it was an Application Fee? lol
FOLLOW THE MONEY!
https://t.me/Mr_Pool_1127_13/384
https://www.rumormillnews.com/cgi-bin/forum.cgi?read=205694
*VERY HOT*! ''SIMILAR TO IVERMECTIN'' 'Early Treatment'!
'On Monday 25 July, China approved the use of the drug “Azvudine” to treat “normal” – i.e. non-severe – forms of Covid-19'.
Manufactured by the Chinese laboratory Genuine Biotech, the originality of the treatment lies in the fact that it is 'initially used against HIV'. Are we to understand that history is proving the late Professor Montagnier right, as Gérard Guillaume predicted?
At the beginning of July, while the laboratory reported good results against “normal” forms of the infection, Azvudine was initially rejected by the Chinese government because it could not treat severe forms. Eventually, the National Medical Products Administration gave a conditional green light to treat adult patients with “normal type” Covid, as reported by the British news agency Reuters. ''Azvudine, taken orally and 'used early', has some similarities to Ivermectin'', another drug that has struggled to win the favour of health authorities.
However, Genuine Biotech’s treatment has one major difference: it is initially used against the AIDS virus, HIV (human immunodeficiency virus). However, as early as 2020, Professor Montagnier supported the 'hypothesis that Covid-19 had been manufactured in the laboratory', in particular with 'HIV sequences': “It’s not natural, it’s the work of a professional, a molecular biologist, a sequence watchmaker. For what purpose? One of my hypotheses is that they wanted to make an AIDS vaccine,” he explained in August of the same year, after conducting his own research.
https://childrenshealthdefense.eu/eu-issues/china-approves-hiv-treatment-to-treat-covid/
DOJ Investigation FAQs Teri Kanefield
https://terikanefield.com/all-new-doj-investigation-faqs/
https://terikanefield.com/
https://terikanefield.com/pubs/